US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Tracks Biotherapeutics Inc

43.11

+1.212.89%

Post-market: 43.440.3321+0.77%19:30 EDT

Volume:527.98K

Turnover:22.82M

Market Cap:1.54B

PE:-9.52

High:44.79

Open:42.98

Low:40.72

Close:41.90

52wk High:49.91

52wk Low:14.72

Shares:35.73M

Float Shares:34.75M

Volume Ratio:0.89

T/O Rate:1.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5296

ROE:-48.91%

ROA:-28.97%

PB:9.13

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc : JP Morgan Raises Target Price to $65 from $30

THOMSON REUTERS

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

Benzinga Earnings

First Tracks Biotherap Price Target Raised to $57.00/Share from $44.00 by HC Wainwright & Co.

Barclays Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc : Piper Sandler Raises Target Price to $95 from $54

THOMSON REUTERS

First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY

Benzinga Earnings

First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million

Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

First Tracks Biotherap Price Target Raised to $65.00/Share from $45.00 by UBS

UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating

MT Newswires Live

First Tracks Biotherapeutics Inc : UBS Raises Target Price to $65 from $45

THOMSON REUTERS

First Tracks Biotherapeutics Inc. : Wells Fargo Raises Target Price to $55 from $30

THOMSON REUTERS

First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo

Top Premarket Gainers

MT Newswires Live

First Tracks is Maintained at Overweight by Barclays

First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from UBS

J.P. Morgan Remains a Buy on First Tracks Biotherapeutics Inc (TRAX)

First Tracks is Maintained at Buy by HC Wainwright & Co.

First Tracks Biotherapeutics, Inc. : H.c. Wainwright Raises Target Price to $44 from $30

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TRAX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":43.11,"timestamp":1787342400000,"preClose":41.9,"halted":0,"volume":527979,"hourTrading":{"tag":"盘后","latestPrice":43.4421,"preClose":43.11,"latestTime":"19:30 EDT","volume":14359,"amount":619055.0136,"timestamp":1787355007160,"change":0.3321,"changeRate":0.007704,"amplitude":0.007704},"delay":0,"changeRate":0.028878281622911717,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"Not Yet Opened","change":1.21,"latestTime":"08-21 16:00:00 EDT","open":42.98,"high":44.785,"low":40.72,"amount":22822161.54429,"amplitude":0.097017,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":41.9,"preHourTrading":{"tag":"盘前","latestPrice":41.9,"preClose":41.9,"latestTime":"08:57 EDT","volume":35,"amount":1462.80995,"timestamp":1787317069997,"change":0,"changeRate":0,"amplitude":0.063962},"postHourTrading":{"tag":"盘后","latestPrice":43.4421,"preClose":43.11,"latestTime":"19:30 EDT","volume":14359,"amount":619055.0136,"timestamp":1787355007160,"change":0.3321,"changeRate":0.007704,"amplitude":0.007704},"volumeRatio":0.8890807450568844,"impliedVol":0.8373,"impliedVolPercentile":0.5972},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.8890807450568844,"shares":35730843,"dividePrice":0,"high":44.785,"amplitude":0.097017,"preClose":41.9,"low":40.72,"week52Low":14.72,"pbRate":"9.13","week52High":49.9114,"institutionHeld":0,"latestPrice":43.11,"eps":-4.529554,"divideRate":0,"volume":527979,"delay":0,"ttmEps":-4.529554,"open":42.98,"prevYearClose":20,"prevWeekClose":44.04,"prevMonthClose":44.04,"prevQuarterClose":20.12,"fiveDayClose":44.04,"twentyDayClose":35.52,"sixtyDayClose":16.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-08-21","current":-9.517493,"percent":0.148148,"low":-10.141689,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"high":-3.156022,"avg":-5.571542,"sd":2.501515,"marketCap":1497122321},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321}],"updateTime":1787546134368},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660893052","title":"Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660893052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660893052?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:20","pubTimestamp":1787224836,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","NA","EQPT","BK4141","ARCT","TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660279495","title":"First Tracks Biotherapeutics Inc : JP Morgan Raises Target Price to $65 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2660279495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660279495?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:33","pubTimestamp":1787067181,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415767","title":"First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415767","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415767?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:07","pubTimestamp":1786626443,"startTime":"0","endTime":"0","summary":"TRAX reported narrower Q2 loss of 95 cents per share. Analysts raised price targets for the stock, citing potential for ANB033 in immune diseases.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61173753/first-tracks-biotherapeutics-analysts-increase-their-forecasts-after-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155006","title":"First Tracks Biotherap Price Target Raised to $57.00/Share from $44.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155006","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659155006?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:59","pubTimestamp":1786618740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659013203","title":"Barclays Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659013203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659013203?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:25","pubTimestamp":1786609539,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $65.00. Darout covers the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659839180","title":"First Tracks Biotherapeutics Inc : Piper Sandler Raises Target Price to $95 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2659839180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659839180?lang=en_us&edition=fundamental","pubTime":"2026-08-13 11:37","pubTimestamp":1786592223,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659513188","title":"First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659513188","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659513188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:38","pubTimestamp":1786567120,"startTime":"0","endTime":"0","summary":"First Tracks (NASDAQ:TRAX) reported quarterly losses of $(0.95) per share. This is a 35.37 percent increase over losses of $(1.47) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61160312/first-tracks-q2-eps-0-95-1-47-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTEC","TQQY","GPIQ","QQQA","QLD","TRAX","QQQE","NDX","JEPQ","NQmain","QQQY","QYLG","NVIW.SI","QQQM","QQQ","TQQQ","PSQ","MNQmain","QDTE","SQQQ","QQQJ","TECS","IYW","BK4139","ONEQ",".IXIC","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918900","title":"First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918900","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:18","pubTimestamp":1786565937,"startTime":"0","endTime":"0","summary":"First Tracks Q2 FY26 net loss narrows to $33.37 millionFirst Tracks posted a Q2 net loss of $33.4 million, narrowing 21.36% from a $42.4 million loss a year earlier.Loss per share improved to $0.95 fr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7xKFl0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","BK4139","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659009089","title":"Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659009089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659009089?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- Completed enrollment for Cohort 1  of Phase 1b ANB033. trial in celiac disease ; top-line Cohort 1 data reaffirmed for Q4. -- Cohort 2  enhanced to enroll up to 40 patients including. those with a broad range of histologic  and symptom. severity to further inform future development; top-line Cohort 2 data. -- U.S. FDA granted Fast Track designation for ANB033 for the treatment of. -- Enrollment ongoing for Phase 1b ANB033 trial in eosinophilic esophagitis. -- Reiterating cash-runway into Q2 2028, including the expansion of ANB033. -- U.S. FDA granted Fast Track designation to ANB033 for the. treatment of people with CeD on a gluten-free diet. -- 70-patient trial assessing one dose level of subcutaneously. -- Cohort 1  is a gluten-challenge study to assess the. -- Cohort 2  assesses the possibility of mucosal healing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLE","RA","BK4139","TRAX","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951302","title":"First Tracks Biotherap Price Target Raised to $65.00/Share from $45.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951302?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:26","pubTimestamp":1786393560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658317769","title":"UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658317769","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658317769?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:29","pubTimestamp":1786368555,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of Buy and mean price target of $53.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931559","title":"First Tracks Biotherapeutics Inc : UBS Raises Target Price to $65 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931559?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367459,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nAZN4TD0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300379","title":"First Tracks Biotherapeutics Inc. : Wells Fargo Raises Target Price to $55 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654300379?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:26","pubTimestamp":1785234413,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nAZN4TAB3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071064","title":"First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071064","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071064?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:35","pubTimestamp":1785224115,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0787776722.HKD","FTXO","PGF","IE00B19Z3B42.SGD","LU0072461881.USD","LU0130102774.USD","LU0320765489.SGD","LU0942090050.USD","LU2236285917.USD","LU0708994859.HKD","LU1201861249.SGD","LU1363072403.SGD","LU0477156953.USD","LU0070302665.USD","LU0106831901.USD","LU0289960550.SGD","LU0048573561.USD","LU1280957306.USD","LU0251142724.SGD","LU0648001328.SGD","BK4207","LU0154236417.USD","LU0149725797.USD","LU0175139822.USD","LU0314106906.USD","LU0267386448.USD","IE0002270589.USD","BK4588","LU0640476718.USD","TRAX","LU0128525689.USD","LU0029864427.USD","LU1035773651.USD","LU0211327993.USD","LU1074936037.SGD","LU0971096721.USD","LU1267930490.SGD","LU0251131958.USD","LU0310799852.SGD","LU0052756011.USD","LU1814569148.SGD","LU0208291251.USD","LU0211328371.USD","LU0162691827.USD","TFNS","LU1267930573.SGD","KBWB","LU0980610538.SGD","IYF","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654540014","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2654540014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654540014?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:04","pubTimestamp":1785150251,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics  shares were up 41% in Monday premarket activity, recovering from a 5.6% loss in the previous session.Baiya International Group  stock was 38% higher, rebounding from a 28% decline in the earlier session.Forte Biosciences  shares were up 39% after Argenx agreed to acquire the company for $77 per share in cash.T3 Defense  stock was 42% higher, adding to an 11.5% gain in the previous session.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","TRAX","DFNS","BK4139","BK4130","FBRX","BIYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653208461","title":"First Tracks is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2653208461","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653208461?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:24","pubTimestamp":1784640240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 09:24 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650138272","title":"First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2650138272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650138272?lang=en_us&edition=fundamental","pubTime":"2026-07-10 21:15","pubTimestamp":1783689330,"startTime":"0","endTime":"0","summary":"In a report released today, from UBS maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of $45.00. Currently, the ana...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650821311","title":"J.P. Morgan Remains a Buy on First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650821311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650821311?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:15","pubTimestamp":1783682114,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Anupam Rama from J.P. Morgan reiterated a Buy rating on First Tracks Biotherapeutics Inc, with a price target of $3...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX","LU1989772923.USD","BK4588","LU0528227936.USD","LU1548497426.USD","LU2028103732.USD","LU0390134368.USD","BK4581","IAI","LU2023251221.USD","LU0106261372.USD","BK4504","BK4534","LU0234570918.USD","LU0795875086.SGD","LU0557290698.USD","LU0795875169.SGD","LU1791710582.SGD","BK4516","LU0006306889.USD","LU1244550577.SGD","LU0053666078.USD","LU1363072403.SGD","KBWB","LU2133065610.SGD","LU2264538146.SGD","LU1720051017.SGD","LU0267386448.USD","LU0158827948.USD","LU0106831901.USD","LU1720051108.HKD","LU0098860793.USD","LU2357305700.SGD","LU2487616109.SGD","BK4139","LU0210528500.USD","LU1074936037.SGD","LU1244550494.USD","LU1732800096.USD","IE00BKVL7J92.USD","LU2089284900.SGD","LU0158827781.USD","LU2089283258.USD","LU2111349929.HKD","IE00BZ1G4Q59.USD","LU0882574139.USD","BK4127","LU2271345857.HKD","BK4585","LU0912757837.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650812001","title":"First Tracks is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2650812001","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650812001?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:23","pubTimestamp":1783678980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings(END) Dow Jones NewswiresJuly 10, 2026 06:23 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650818901","title":"First Tracks Biotherapeutics, Inc. : H.c. Wainwright Raises Target Price to $44 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2650818901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650818901?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:04","pubTimestamp":1783677894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nAZN4T73S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}